Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM

首页> 外文期刊>Journal of the Endocrine Society. >Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM

【24h】

Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM

机译：错误至：胰高血糖素类肽-1受体激动剂与钠葡萄糖COTRANSPORTER抑制剂进行治疗T2DM

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

[This corrects the article DOI: 10.1210/jendso/bvaa037.].? The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society.

机译：[这将更正文章DOI：10.1210 / JENDSO / BVAA037。]。？作者2021年。由牛津大学出版社代表内分泌社会出版。

著录项

来源
《Journal of the Endocrine Society.》 |2021年第3期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM [J] . McKee Alexis, Al-Khazaali Ali, Albert Stewart G Journal of the Endocrine Society. . 2020,第5期

机译：胰高血糖素肽-1受体激动剂与钠 - 葡萄糖COT转换器抑制剂治疗T2DM
2. Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review [J] . Hong Dongzhe, Si Lei, Jiang Minghuan, PharmacoEconomics . 2019,第6期

机译：钠葡萄糖COTRANSPORPOR-2（SGLT2）抑制剂，胰高血糖素样肽-1（GLP-1）受体激动剂和二肽基肽酶-4（DPP-4）抑制剂的成本有效性：系统审查
3. Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review (vol 37, pg 777, 2019) [J] . Hong Dongzhe, Si Lei, Jiang Minghuan, PharmacoEconomics . 2019,第12期

机译：钠 - 葡萄糖Cotroansporter-2（SGLT2）抑制剂，胰高血糖素样肽-1（GLP-1）受体激动剂和二肽基肽酶-4（DPP-4）抑制剂的成本有效性：系统评价（Vol 37，PG 777， 2019）
4. Conformational Dynamics of Large "Two-Headed Ligand Keys": Unlocking the Glucagon-Like Peptide-1 Receptor Signaling Pathway [C] . Graham M. West, Kyle W. Sloop, Francis S. Willard, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：大“双头配体键”的构象动态：解锁胰高血糖素样肽-1受体信号传导路径
5. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment. [D] . Hart, Nathaniel. 2013

机译：使用互补的多价胰高血糖素样肽-1 /格列苯脲酰胺配体对胰高血糖素样肽-1和磺酰脲-1受体进行联合靶向，以改善β细胞靶向剂和糖尿病治疗。
6. Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM [O] . Alexis McKee, Ali Al-Khazaali, Stewart G Albert 2020

机译：胰高血糖素样肽-1受体激动剂与钠-葡萄糖共转运蛋白抑制剂治疗T2DM
7. PDG15 ECONOMIC ASSESSMENT OF SWITCHING FROM DIPEPTIDYL PEPTIDASE-4 INHIBITORS TO SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS OR GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST USING REAL-WORLD DATA [O] . S.K. Peasah, K. Munshi, E. Swart, 2020

机译：PDG15通过使用现实世界数据从二肽肽肽酶-4抑制剂从二肽肽肽酶-4抑制剂切换到葡萄糖COTRANSPORPER 2抑制剂或胰高血糖素样肽-1受体激动剂的经济评估

Erratum to: Glucagon-like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter Inhibitors for Treatment of T2DM

摘要

著录项

相似文献

相关主题

期刊订阅